- Staat
- CA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cold sweat
Head titubation
Lethargy
Malaise
Pallor
Syncope
Symptomtext
Boostrix administered first. Then Varivax. Was talking to mom and patient, and patient said she didn't feel well, then head fell back (in chair) - she fainted. She came to quickly, but was pale, clammy and lethargic. Paramedics and Fire Department arrived shortly after, evaluated her vitals, watched her for a while, and advised mom it looked like she fainted, and was looking more back to normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- none
- Andere Medikamente
- unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 23.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Symptomtext
On 1/25/22, Patient contacted Nurse to report numbness and tingling to her L arm and right leg that started the day after receiving the listed 5 vaccinations. Nurse referred her to clinic. On 1/31/22 she had her first clinic visit where she was instructed to use ice 2-3 times per day, 15 min. at a time, home stretches, and follow up in 2 weeks. Regular duty. Second clinic visit on 2/7/22 added prednisone to the treatment regime with follow up in 10 days. Third clinic visit on 2/15/22 added Gabipentin and Physical Therapy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None known
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Lyme Disease (10 Years ago),
- Andere Medikamente
- Spironolactone, Kylena IUD, Vitamin C
- Allergien
- Egg intolerance (Nausea/vomiting after consumption).
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 25.08.2022
- Impfdatum
- 22.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Chills
Cough
Gait inability
Injection site erythema
Injection site reaction
Lacrimation increased
Pyrexia
Rhinorrhoea
Urticaria
Symptomtext
Mom messaged me the following the day after immunization: He?s been really weak, with a fever and chills all day complaining he can?t walk. The injection site on his left thigh is a large red welt, several inches wide and raised, and then he?s developed several large, puffy welts on his right thigh as well. His eyes are really watery, with a slight runny nose and coughing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- -
- Allergien
- Cinnamon - mild Oseltamivir - hives
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 06.04.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site induration
Injection site warmth
Rash
Symptomtext
There is redness warmth and induration from her left mild deltoid area o almost the elbow. Kinrix and Varicella were given on L deltoid. Benadryl and Ibuprofen given in clinic. Rash showed some improvement with Benadryl and Ibuprofen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Complex Febrile Convulsions
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 15.06.2023
- Impfdatum
- 03.04.2023
- Beginn
- 15.06.2023
- Tage bis Beginn
- 73,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
the patient had no symptoms after given the vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- The doctor approved the vaccine but neither I, the doctor or the patient knew if he was immune to the vaccine given (varicella) - the patient also did request the vaccine himself due to the unknown immunity
- Aktuelle Erkrankungen
- HIV (human immunodeficiency virus) infection hypothyroidism history of alcohol abuse
- Vorgeschichte
- HIV (human immunodeficiency virus) infection hypothyroidism
- Andere Medikamente
- Biktarvy 50mg-200mg-25mg tablet levothyroxine 25 mcg tablet
- Allergien
- Kaletra
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 06.03.2023
- Impfdatum
- 06.03.2023
- Beginn
- 06.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Pt. was given an expired Kinrix vaccine EXP 03/03/2023, child was doing fine. Mother was notified of incident and follow up appointment given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine.; This spontaneous report was received from a physician and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-SEP-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, dose and route of administration were not provided) (product storage error). Administered dose of vaccine underwent temperature excursion: -12.5 Celsius degrees for 1 hour. None previous temperature excursion was noted. No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.10.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine.; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-SEP-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, dose and route of administration were not provided) (product storage error). Administered dose of vaccine underwent temperature excursion: -12.5 Celsius degrees for 1 hour. No previous temperature excursion was noted. No additional adverse event was report (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.10.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine. No additional AEs were reported, no further information provided. Names of vaccines involved (including lot/exp) VARIVAX (u024221 8/4/2023) Temperature: -12.5C Time frame:; This spontaneous report was received from a physician regarding a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 06-SEP-2022, the patient was vaccinated with an improperly stored vaccine of varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis, lot # U024221 with expiration date on 04-AUG-2023 (strength, dose number, anatomical location and route of administration). The temperature storage was -12.5 C for a time frame of 1 hour, without a previous temperature excursion. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.10.2022
- Impfdatum
- 10.09.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; patient received improperly stored vaccine; This spontaneous report was received from physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-SEP-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #u024221, expiration date: 04-AUG-2023, administered for prophylaxis (dose, strength, and route of administration were not provided) (Product storage error). Administered dose of vaccine experienced the temperature excursion of -12.5 degrees Celsius (C) for 1 hour. There was no previous temperature excursion. There was no adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.10.2022
- Impfdatum
- -
- Beginn
- 10.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; improperly stored vaccine; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #u024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, dose and route of administration were not provided) (product storage error). On 10-SEP-2022, administered dose of vaccine experienced the temperature excursion of -12.5 degrees Celsius for 1 hour. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.10.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported.; The physician reported that a patient received improperly stored vaccine.; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies or reactions and concomitant medications was not provided. On 14-SEP-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX), lot number u024221 had been verified to be a valid number; expiration date 04-AUG-2023, and upon internal validation established as the same date, as prophylaxis (dosage, vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported) following a temperature excursion of minus 12.5 degrees Celsius (C), during a time frame of 1 hour, it was stated that no previous temperature excursion occurred. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AEs were reported; The physician reported that a patient received improperly stored vaccine. No additional AEs were reported, no further information provided. Names of vaccines involved (including lot/exp) VARIVAX (u024221 8/4/2023) Temperature: -12.5C Time frame:; This spontaneous report was received from a physician and refers to a patient of unspecified age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-SEP-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # u024221, expiration date 04-AUG-2023 (dose, route of administration and anatomical location were not reported). Administered vaccine was improperly stored in temperature of -12.5 degrees Celsius (product storage error, temperature too high) for 1 hour. There were no previous temperature excursion reported. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 20.08.2022
- Impfdatum
- 18.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered at inappropriate site
Symptomtext
Medication given IM instead of subq
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered at inappropriate site
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
administered too early, at 6mo visit instead of 1 year visit due to order error
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- possible congenital syphilis prenatal substance exposure
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effects or symptoms following administration; Caller is a medical assistant who reports administration of VARIVAX following temperature excursion.; This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On 10-MAY-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) at a dose of 0.5 milliliter (ml) once (vaccination scheme frequency, route of administration and anatomical site of injection were not reported; lot number U024221 that was verified to be a valid lot number with an expiration date reported and established as 08-APR-2023) for prophylaxis, following a temperature excursion of 12 degrees Fahrenheit (F) with a time frame of 22 hours (product storage error). It was reported that there was no previous temperature excursion. There were no adverse effects or symptoms following the administration (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.05.2022
- Impfdatum
- 14.04.2022
- Beginn
- 14.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Patient did not have any symptoms or adverse effects of receiving vaccine; administration of vaccine following temperature excursion/ Temperature: -13.0C; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and previous drug reactions or allergies were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT). On 14-APR-2022, the patient was administered varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml) once for prophylaxis following a temperature excursion of -13.0 Celsius (C) for 1 hour (product storage error) (valid lot number U024221, with expiration date 04-AUG-2023; dose number, vaccination scheme, route and anatomical location of vaccination were not reported). There was no previous temperature excursion. The patient did not have any symptoms or adverse effects from receiving the vaccine (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- MERCK STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
pt did not have any symptoms or adverse effects of receiving vaccine; administration of vaccine following temperature excursion; This spontaneous report was received from a medical assistant and refers to a specified patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent (manufacturer unknown). On 08-APR-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter/once, lot # U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, anatomical location and route of administration were not provided). Prior to being administered, the vaccine underwent a temperature excursion of -13 degrees Celsius for 1 hour (product storage error). Patient did not have any symptoms or adverse effects of receiving the vaccine (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.05.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
a dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report has been received from a pharmacy technician by a nurse at one of their facility's clinic, referring to a patient of unknown age and gender. The patient's concomitant medication, historical condition and current condition were not reported. On 04-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) (1 dose, lot# U028179 with expiration date: 08-MAR-2023, route and strength were unknown) and varicella virus vaccine live (oka/merck)(VARIVAX) (1 dose, lot# U024221 with expiration date: 04-AUG-2023, strength and route were unknown), both for prophylaxis (overdose). It is unknown to caller if any product confusion occurred. No further information provided. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004906: US-009507513-2204USA004990: US-009507513-2204USA005095: US-009507513-2204USA005731: US-009507513-2204USA005733: US-009507513-2204USA005079: US-009507513-2204USA005255:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.05.2022
- Impfdatum
- -
- Beginn
- 29.03.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
A dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report has been received from a pharmacy technician referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not provided. On 29-APR-2022 the patient was vaccinated with one dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) as prophylactic vaccination ( dose, route of administration, anatomical location and vaccination scheme frequency were not provided) lot number U024221 has been verified to be a valid lot number, expiration date 04-AUG-2023, and with one dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (recombinant human albumin rHA) (PROQUAD) (dose, route of administration, anatomical location and vaccination scheme frequency were not provided) lot number U028179 has been verified to be a valid lot number, expiration date 08-MAR-2023 (vaccine overdose). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004990: US-009507513-2204USA005095: US-009507513-2204USA005731: US-009507513-2204USA005733: US-009507513-2204USA005079: US-009507513-2204USA005707:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product use issue
Symptomtext
Caller is a pharmacy technician (listed as technician in additional case contacts, as pharmacy technician is not listed) who is reporting that a dose of PROQUAD was administered with VARIVAX for 8 different patients. Caller reports the information; Caller is a pharmacy technician (listed as technician in additional case contacts, as pharmacy technician is not listed) who is reporting that a dose of PROQUAD was administered with VARIVAX for 8 different patients. Caller reports the information; This spontaneous report was received from a pharmacy technician referring to a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies were not reported. On 29-MAR-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (Rha) (PROQUAD) (lot number U028179 has been verified to be valid, expiration date reported and established as 08-MAR-2023). On the same date, the patient was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U024221 has been verified to be valid, expiration date reported and established as 04-AUG-2023) (product use issue, inappropriate schedule of product administration). Both vaccines were administered as prophylaxis.; Sender's Comments: US-009507513-2204USA004906: US-009507513-2204USA005095: US-009507513-2204USA005731: US-009507513-2204USA005733: US-009507513-2204USA005079: US-009507513-2204USA005707: US-009507513-2204USA005707:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; administration of vaccine following temperature excursion; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and previous drugs reactions or allergies were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT). On 11-APR-2022,the patient was vaccinated with a improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter/once (lot number U024221, has been verified to be valid, expiration date: 04-AUG-2023), administered for prophylaxis (route of administration were not provided). Patient did not have any symptoms or adverse effects of receiving vaccine (also reported as no adverse event). The stored temperature was -13.0 degrees Celsius (C) and the time frame was reported as 1 hour. There was no previous temperature excursion. No further information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
a dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-MAR-2022, the patient received varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided); and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 1 dose, lot #U028179, expiration date: 08-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided) (overdose). It is unknown if any product confusion occurred, that may have contributed to the error. No further information provided. No product quality complaints. This is one of eight reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004906:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.04.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
a dose of PROQUAD was administered with VARIVAX; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. On 08-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot #U024221, expiration date 04-AUG-2023 (strength and route were not provided), with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) 1 dose, lot #U028179, expiration date 08-MAR-2023 (strength and route were not provided) for prophylaxis (overdose). The pharmacy technician reported the information was shared with her by a nurse at one of their facility's clinic. It was unknown if any product confusion occurred, that may have contributed to the error. This is one of eight reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
a dose of PROQUAD was administered with VARIVAX; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. On 04-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot #U024221, expiration date 04-AUG-2023 (strength and route were not provided), with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) 1 dose, lot #U028179, expiration date 08-MAR-2023 (strength and route were not provided) for prophylaxis (overdose). The pharmacy technician reported the information was shared with her by a nurse at one of their facility's clinic. It was unknown if any product confusion occurred, that may have contributed to the error. This is one of eight reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2022
- Impfdatum
- 07.04.2022
- Beginn
- 07.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered at inappropriate site
Symptomtext
no further information provided; Caller is a pharmacy technician (listed as technician in additional case contacts, as pharmacy technician is not listed) who is reporting that a dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report was received from a registered nurse via a pharmacy technician from same facility clinic and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not provided. On 07-APR-2022, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U024221, expiration date was provided and also validated as 04-AUG-2023; and also with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # U028179, expiration date was reported and also validated as 08-MAR-2023; for prophylaxis (exact doses, route of administration and anatomical location were not provided for both vaccines) (overdose). It was unknown to caller if any product confusion occurred that might had contributed to the error. No further information was provided (no adverse event). This is one of several linked reports received from the same reporter.; Sender's Comments: US-009507513-2204USA005095: US-009507513-2204USA004906: US-009507513-2204USA004990: US-009507513-2204USA005079: US-009507513-2204USA005733:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered at inappropriate site
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.04.2022
- Impfdatum
- 06.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Vaccination error
Symptomtext
a dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. On 06-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot #U024221, expiration date 04-AUG-2023 (strength and route were not provided), with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) 1 dose, lot #U028179, expiration date 08-MAR-2023 (strength and route were not provided) for prophylaxis (overdose). The pharmacy technician reported the information was shared with her by a nurse at one of their facility's clinic. It was unknown if any product confusion occurred, that may have contributed to the error. This is one of eight reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 1,9
- Geschlecht
- U
- Eingang
- 16.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No additional AE reported; an expired vial of STERILE DILUENT was accidently used to reconstitute a dose of MMR II and VARIVAX and then was administered to a patient. The vial of STERILE DILUENT expired on Mar 24 2022, and was used and administered on Apr 5, 2022; an expired vial of STERILE DILUENT was accidently used to reconstitute a dose of MMR II and VARIVAX; This spontaneous report was received from a registered nurse referring to a 23 months old patient. Information about medical history, concurrent conditions and concomitant therapies was not provided. The reporter stated that an expired vial of sterile diluent (STERILE DILUENT) (lot # S026376, expiration date reported as 24-MAR-2022, but upon internal validation established as 24-MAR-2020, once; strength, dose, route were not reported) was accidently used to reconstitute a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot number: T029549, expiration date reported as 01-SEP-2022, but upon internal validation established as 10-SEP-2022, once; route not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot number: U024221, expiration date: 04-AUG-2023, once; dose and route were not reported) as prophylaxis, and then was administered to the patient on 05-APR-2022 (expired product administered, product preparation error). The sterile diluent (STERILE DILUENT) had no prior temperature excursions. No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Medication dilution
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 12.03.2022
- Impfdatum
- 07.12.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
A patient received improperly stored vaccine; No additional AEs were reported; This spontaneous report was received from a medical assistant regarding a 1-year-old patient of unspecified gender. Information regarding medical history, concurrent conditions and concomitant medications was not reported. On 07-DEC-2021, the patient received an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) as prophylaxis (lot number U024221 and expiration date 04-AUG-2023; both verified as valid (expiration date was reported as 04-OCT-2023)) (no more vaccination details provided). The vaccine had a temperature excursion of 39.5 Fahrenheit (F) for a time frame of 10 hours; there was no previous temperature excursion. No additional adverse events (AEs) were reported, no further information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; patient received improperly stored vaccine; This spontaneous report was received from a medical assistant, and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 13-DEC-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX), 1 dose, lot # U024221, expiration date reported as 04-OCT-2023, but upon internal validation established as 04-AUG-2023 (dose number and exact route of administration were not provided) for prophylaxis (Product storage error). The vaccine had been improperly stored in the temperature of 39.55 Fahrenheit degrees (F) for 10 hours with no previous temperature excursion. It was unknown if digital data logger was involved. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.03.2022
- Impfdatum
- 14.12.2021
- Beginn
- 14.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
no additional AEs were reported; a patient received improperly stored vaccine.; This spontaneous report was received from a medical assistant, referring to a 12 months old patient of unknown gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 14-DEC-2021 the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U024221 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck), expiration date reported as 04-OCT -2023, but upon internal validation established as 04-AUG-2023; 1 dose, route and expiration date were unknown) for prophylaxis (product storage error). No additional AEs were reported, no further information provided Administered dose of varicella virus vaccine live (oka/merck)(VARIVAX) experienced the temperature excursion below 39.55 Fahrenheit degrees for 10 hours. There was no previous temperature excursions reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,1
- Geschlecht
- U
- Eingang
- 10.03.2022
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; a patient received improperly stored vaccine; This spontaneous report was received from a Medical Assistant referring to a 13 month old patient (gender not specified). The patient's concurrent conditions and medical history were not reported. There was no concomitant medication reported. On 13-DEC-2021, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U024221; expiration date: 04-OCT-2023) for prophylaxis which was improperly stored. It was mentioned that the temperature was 39.55 degrees Farhenheit for a time frame of 10 hours. There were no previous temperature excursion. No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- M
- Eingang
- 08.03.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE information provided; temperature excursion; This spontaneous report was received from a registered nurse and refers to a male patient of unknown age. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported. On 09-FEB-2022, the patient was administered with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U024221 was verified to be valid, expiration date reported and established as 04-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided). The administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) previously experienced a temperature excursion of 6 to 14 Fahrenheit (F) degrees (6.4F) for 15 minutes. No other information was available at this time. The vaccine had no previous temperature excursions. The patient did not experience any other adverse events.; Sender's Comments: 2202USA004245:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.03.2022
- Impfdatum
- 12.09.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 88,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; patient received improperly stored vaccine; This spontaneous report was received from a medical assitant and refers to a 13-month-old (gender not reported). The patient's concurrent conditions, medical history or concomitant medications were not provided. On 12-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dosage form, lot #U024221, has been verified to be a valid lot number for varicella virus vaccine live, expiration date reported as 04-OCT-2023, but upon internal validation established as 04-AUG-2023)administered for prophylaxis (strength, and route of administration were not provided). The vaccine had been improperly stored at a temperature of 39.55F for a time fram of 10 hours. There was no previous temperature excursion. No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,2
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 07.12.2021
- Beginn
- 07.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; The medical assistant is reporting that a patient received improperly stored vaccine; This spontaneous report was received from a Medical Assistant, referring to a 58-week-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided. On 07-DEC-2021, the patient was vaccinated with one improper stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot number reported as U024221 and expiration date reported as 04-OCT-2023; route of administration, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported) (product storage error). The administered dose of the vaccine experienced a temperature excursion of 39.55 degrees Fahrenheit (F) for 10 hours. There was no previous temperature excursion reported. No adverse events were reported. Lot number U024221 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date reported as 04-OCT-2023 but upon internal validation established as 04-AUG-2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,1
- Geschlecht
- U
- Eingang
- 18.02.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs reported; patient received improperly stored vaccine; This spontaneous report was received from a medical assistant referring to a 13-month-old patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 15-DEC-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose, lot number U024221, expiration date 04-OCT-2023 (route of administration not reported) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 39.55 degrees Fahrenheit for 10 hours. No previous temperature excursions were detected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,1
- Geschlecht
- U
- Eingang
- 16.02.2022
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; patient received improperly stored vaccine; This spontaneous report was received from a medical assistant referring to a 13-month-old patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 13-DEC-2021, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose, lot number U024221, expiration date 04-OCT-2023 (route of administration not reported) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 39.55 degrees Fahrenheit for 10 hours with no previous excursions reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.02.2022
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; a patient received improperly stored vaccine; This spontaneous report was received from a medical assistant referring to a 12 month old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-DEC-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) subcutaneous injection,1 dose, lot # U024221, expiring on 04-OCT-2023, for prophylaxis (strength, route and site of administration were not provided). The administered dose of the vaccine experienced a temperature excursion of 39.55F for 10 hours (product storage error). The vaccine had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.01.2022
- Impfdatum
- 11.12.2021
- Beginn
- 11.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AE; administered IM instead of SC; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. Information regarding the patient's concomitant therapies, current conditions, medical history and historical drug was not provided. On 11-DEC-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) intramuscular route (Incorrect route of product administration) lot number U024221 expiration date 04-AUG-2023 (dosage regimen was not provided) as prophylaxis. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 11.12.2021
- Impfdatum
- 11.12.2021
- Beginn
- 11.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Symptomtext
Patient received her second dose varicella vaccine. Vaccine administered IM instead of deltoid area in left arm No adverse reaction noted at the time in clinic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -